Martha Schlicher - Jul 24, 2023 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC (GRNA)

Role
Director
Signature
/s/ Martha Schlicher
Stock symbol
GRNA
Transactions as of
Jul 24, 2023
Transactions value $
-$32,765
Form type
4
Date filed
7/26/2023, 07:21 PM
Previous filing
Aug 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRNA Common Stock Disposition pursuant to a tender of shares in a change of control transaction -$32.8K -109K -100% $0.30 0 Jul 24, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Martha Schlicher is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2023, by and among GreenLight Biosciences Holdings, PBC ("Issuer"), SW ParentCo, Inc. ("Parent"), and SW MergerCo, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), to which Merger Sub completed a tender offer for shares of common stock of the Issuer, $0.0001 par value per share (each, a "Share"), and thereafter merged with and into the Issuer effective as of July 24, 2023 (the "Effective Time"). At the Effective Time, each issued and outstanding Share was converted into the right to receive $0.30 per Share, in cash, without interest and subject to any withholding of taxes, upon the terms and subject to the conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled.